HomeSPRINT • STO
add
Sprint Bioscience AB
Previous close
kr 0.66
Day range
kr 0.66 - kr 0.67
Year range
kr 0.60 - kr 2.21
Market cap
77.29M SEK
Avg Volume
141.51K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 16.77M | 38.82% |
Operating expense | 13.16M | 19.39% |
Net income | -4.21M | 16.51% |
Net profit margin | -25.11 | 39.87% |
Earnings per share | — | — |
EBITDA | -3.21M | -36.90% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 25.06M | -49.82% |
Total assets | 42.06M | -32.58% |
Total liabilities | 32.78M | -5.26% |
Total equity | 9.27M | — |
Shares outstanding | 69.82M | — |
Price to book | 5.08 | — |
Return on assets | -18.42% | — |
Return on capital | -71.30% | — |
Cash Flow
Net change in cash
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -4.21M | 16.51% |
Cash from operations | -6.12M | -128.09% |
Cash from investing | -541.00K | 77.95% |
Cash from financing | 0.00 | — |
Net change in cash | -6.66M | -29.68% |
Free cash flow | -4.48M | -175.40% |
About
Founded
2009
Website
Employees
38
